GlassScriptPhysician profile
Anita E Spiess
NPI 1609857457
$3,937.47
in general payments reported to CMS, 2019-2025
37 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $899 · 2020: $410 · 2021: $452 · 2022: $812 · 2023: $763 · 2024: $461 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,365.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $894.43 | 2019-2025 | Skyrizi, Rinvoq, Viberzi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $564.48 | 2019-2024 | Xifaxan, Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $399.99 | 2019-2023 | Entyvio |
| Celgene Corporation | $212.86 | 2021-2024 | Zeposia |
| Gilead Sciences, INC. | $173.74 | 2021-2025 | |
| Intercept Pharmaceuticals, INC. | $159.28 | 2020-2023 | Ocaliva |
| Janssen Biotech, INC. | $145.44 | 2019-2022 | |
| Intuitive Surgical, INC. | $136.18 | 2021-2023 | Da Vinci Surgical System |
| Ironwood Pharmaceuticals, INC | $124.92 | 2019-2023 | Linzess |
| Ferring Pharmaceuticals INC. | $123.24 | 2021-2023 | Rebyota |
| Pfizer INC. | $108.92 | 2019-2023 | |
| Allergan, INC. | $74.66 | 2019 | |
| Phathom Pharmaceuticals, INC. | $71.59 | 2023-2025 | Voquezna |
| Ucb, INC. | $68.83 | 2019-2020 | |
| Ardelyx, INC. | $59.19 | 2022-2024 | Ibsrela |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anita Spiess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.